Healthcare

PREVENT HPV Cancers Act of 2023

United States · United States Congress · 24 May 2023

Promoting Resources to Expand Vaccination, Education and New Treatments for HPV Cancers Act of 2023 or the PREVENT HPV Cancers Act of 2023 This bill requires the Centers for Disease Control and Prevention to carry out a campaign to raise awareness about human papilloma virus (HPV) vaccination with a particular focus on combatting misinformation and increasing vaccination rates, especially among males. The bill also reauthorizes through FY2028 the Breast and Cervical Cancer Early Detection Program and otherwise extends activities to reduce breast and cervical cancer mortality.

Toxic-Free Beauty Act of 2023

United States · United States Congress · 24 May 2023

Toxic-Free Beauty Act of 2023 This bill prohibits the use of certain chemical substances (e.g., formaldehyde) in cosmetic products.

Cosmetic Safety for Communities of Color and Professional Salon Workers Act of 2023

United States · United States Congress · 24 May 2023

Cosmetic Safety for Communities of Color and Professional Salon Workers Act of 2023 This bill establishes several programs and requirements to address harmful chemicals in cosmetics and their effects on customers and salon workers, particularly in communities of color. For example, the bill requires the Department of Health and Human Services (HHS) to award grants to nonprofits and educational institutions to research harmful chemicals in cosmetics that are primarily marketed to and used by women and girls of color. HHS must publish a report summarizing the research, including recommendations for reducing exposure to such harmful cosmetics. HHS must similarly award grants for research, and publish a related report, about harmful chemicals in products that are used by professional nail, hair, and beauty salon workers. In addition, the Food and Drug Administration must award grants to support the development of alternative, safer chemicals that may be used in place of harmful chemicals in cosmetics. HHS must also establish a National Resource Center on Beauty Justice and a National Resource Center on Salon Worker Health and Safety to educate customers and salon workers, respectively, about harmful chemicals in cosmetics, with a particular focus on communities of color. The Department of Labor must require manufacturers of professional cosmetics to prepare and publish product safety sheets that identify harmful chemicals in their products. Salon owners and operators must also provide product safety sheets to their employees.

Cosmetic Fragrance and Flavor Ingredient Right to Know Act of 2023

United States · United States Congress · 24 May 2023

Cosmetic Fragrance and Flavor Ingredient Right to Know Act of 2023 This bill imposes disclosure and labeling requirements on cosmetic products that contain certain ingredients. A cosmetic product that fails to meet such requirements may not be sold. Within two years of this bill's enactment, a cosmetic product's labeling or packaging must include a full list of its ingredients, as well as a specified statement that directs consumers to the brand owner's website for the health impacts of any ingredient that (1) is identified on specified lists of harmful or potentially harmful chemicals, such as chemicals identified as carcinogenic to humans by the Environmental Protection Agency or toxic air contaminants under California regulations; or (2) must be disclosed under certain European Union laws and is present in a product above specified concentrations. The Food and Drug Administration must publish and periodically update on its website a list of the ingredients subject to this requirement. Within one year of this bill's enactment, a brand owner must disclose the full list of ingredients for each cosmetic product on its website, as well as whether a cosmetic product contains any fragrance or flavor ingredient that is subject to this bill's labeling or packaging requirement and, if so, the ingredient's functional purpose.

Cosmetic Supply Chain Transparency Act of 2023

United States · United States Congress · 24 May 2023

Cosmetic Supply Chain Transparency Act of 2023 This bill requires the Food and Drug Administration (FDA) to maintain a list of certain nonfunctional constituents in cosmetics that are harmful to human health or the environment, authorizes the FDA to request from a brand owner (i.e., the entity bringing a cosmetic to market) certain information about a cosmetic's ingredients, and addresses related issues. For each listed nonfunctional constituent, the list must identify the ingredient or cosmetic (or category of ingredient or cosmetic) in which the constituent is known or reasonably expected to be present. The FDA must also (1) establish procedures for petitions to add substances to the list, (2) issue guidance for industry related to testing and detecting such nonfunctional constituents, and (3) establish a committee to provide advice on creating the list and developing the required industry guidance. Within a year of a nonfunctional constituent being added to the list, a supplier of an ingredient or cosmetic must test for that constituent and provide a brand owner the results and other information before selling the ingredient or cosmetic to the brand owner. A supplier of an ingredient or cosmetic must provide additional information about the item upon a brand owner's request. Brand owners must maintain records with information about the suppliers of ingredients and raw materials used in their cosmetics and provide such information to the FDA upon request. The bill also imposes civil penalties for brand owners and suppliers that violate this bill's provisions.

State Strategic Stockpile Act of 2023

United States · United States Congress · 24 May 2023

State Strategic Stockpile Act of 2023 This bill reauthorizes through FY2028 a pilot program that provides support to states, or consortia of states, to establish, expand, or maintain stockpiles of drugs, vaccines, and other medical supplies necessary to respond to a declared public health emergency.

To amend the Public Health Service Act to establish emergency grants to safeguard essential health care workers, and for other purposes.

United States · United States Congress · 24 May 2023

This bill authorizes the Department of Health and Human Services to award grants to public or private nonprofit health care facilities and home health agencies for hazardous pay for essential health care workers during declared emergencies or disasters. Health care workers may receive up to $13 per hour (up to $25,000 per year) in hazardous pay. Grants may also be used to provide other safety and supportive services for health care workers, such as personal protective equipment.

THE ROLE OF PHARMACY BENEFIT MANAGERS IN PRESCRIPTION DRUG MARKETS PART I: SELF-INTEREST OR HEALTHCARE?

United States · United States House of Representatives · 23 May 2023

Doctors at the Ready Act

United States · United States Congress · 23 May 2023

Doctors at the Ready Act This bill permanently authorizes the Department of Health and Human Services (HHS) to directly appoint candidates to positions within the National Disaster Medical System if HHS determines the number of personnel in the system is insufficient to address a public health emergency or potential public health emergency. Currently, the authorization expires on September 30, 2023. The National Disaster Medical System is a partnership between HHS, the Department of Defense, and other federal departments that responds to public health and other emergencies, including by deploying medical response teams.

To amend title 10, United States Code, to expand the authority to provide a wig and treat traction alopecia under the TRICARE program, and for other purposes.

United States · United States Congress · 23 May 2023

This bill expands primary and preventative health care services for women under TRICARE to include health care services for traction alopecia. The bill also authorizes the provision of a wig for traction alopecia. (Under current law, wigs are only authorized for individuals with alopecia resulting from the treatment of a malignant disease). Additionally, the bill requires the implementation of regulations regarding grooming standards and training materials to ensure members of the Armed Forces are warned that the prolonged use of tightly gathered hairstyles, dyes, and chemical hair products may cause health issues, such as traction alopecia.

PATIENT Act of 2023

United States · United States Congress · 22 May 2023

Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023 This bill expands hospital price transparency requirements and establishes additional reporting requirements with respect to prescription drugs and pharmacy benefit managers (PBMs). The bill also extends funding for various programs such as the Teaching Health Center Graduate Medical Education program, Community Health Center program, and National Health Service Corps. Specifically, the bill provides statutory authority for the requirement that hospitals publish an annual list of shoppable services they provide, including specified pricing information. Beginning in 2025, a hospital may not use an internet-based price estimator tool to meet the publication requirement for shoppable services. The bill also modifies the health insurance plan disclosure requirements to include the rates for certain in-network services and prescription drug payment information. The bill further requires providers of diagnostic laboratory tests under Medicare to publish online certain price information. Medicare Advantage (MA) organizations must report information about payments made to providers in which the MA organization has an ownership interest. Medicare prescription drug plan sponsors must report certain price information for covered drugs. Additionally, the bill requires health insurance plan issuers (or the PBM providing services on behalf of the plan) to report to the plan sponsor specified information about prescription drugs dispensed under the plan. This includes rebates, fees, alternative discounts, or other remuneration the plan receives from drug manufacturers. Finally, the bill requires pass-through pricing models, and prohibits spread-pricing, for payment arrangements with PBMs under Medicaid.

Affordability is Access Act of 2023

United States · United States Congress · 22 May 2023

Veterans CARE Act

United States · United States Congress · 22 May 2023

Veterans Cannabis Analysis, Research, and Effectiveness Act or the Veterans CARE Act This bill requires the Department of Veterans Affairs (VA) to conduct and support research on the efficacy and safety of certain forms of cannabis and cannabis delivery for veterans enrolled in the VA health care system and diagnosed with conditions such as chronic pain or post-traumatic stress disorder. Collected data shall be preserved in a manner that facilitates further research.

Supporting the goals and ideals of the month of May as Sex Ed For All Month: Equity and Access for All.

United States · United States Congress · 22 May 2023

This resolution expresses support for the goals and ideals of Sex Ed For All Month.

Declaring a mental health crisis among youth in the United States, and expressing the pressing need for historic investments in mental health care for students.

United States · United States Congress · 22 May 2023

This resolution recognizes that there is a mental health crisis among youth in the United States and encourages various efforts to address the crisis.

Medical and Health Stockpile Accountability Act of 2023

United States · United States Congress · 22 May 2023

Medical and Health Stockpile Accountability Act of 2023 This bill requires the Office of the Assistant Secretary for Preparedness and Response, which is a part of the Department of Health and Human Services, to develop an automated application to track the amount of supplies in the Strategic National Stockpile and in similar inventories maintained by states, tribes, territories, and private entities (e.g., hospitals). Additionally, the office must (1) provide for an annual exercise to test the effectiveness of the application, and (2) establish a program to assist health care entities in obtaining automated vendor management systems.

Real Education and Access for Healthy Youth Act of 2023

United States · United States Congress · 22 May 2023

Real Education and Access for Healthy Youth Act of 2023 This bill requires the Department of Health and Human Services (HHS) to establish grants to support sex education and sexual health services for young people (ages 10 through 29) and repeals requirements that apply to certain federally funded sex education programs. HHS must award grants, in coordination with the Department of Education, to (1) provide sex education to young people; and (2) train education professionals to effectively teach, and otherwise support, sex education. Sex education refers to high quality teaching and learning that follows, to the maximum extent practicable, specified educational standards; covers a variety of topics concerning sex and sexuality; explores values and beliefs about those topics; and helps young people gain skills to navigate relationships and manage sexual health. Additionally, HHS must award grants to youth-serving organizations and health care entities that are eligible to receive covered outpatient drugs at reduced prices through the 340B drug discount program for providing sexual health services to marginalized youth. Recipients of any of these grants must comply with certain nondiscrimination requirements. In addition, they may not use funds for sex education programs or sexual health services that provide incomplete or inaccurate medical information or fail to address specified issues. The bill also eliminates prohibitions regarding the content of specified federally funded sexual health education and information programs and repeals the Abstinence Only Until Marriage program.

PACE Part D Choice Act of 2023

United States · United States Congress · 18 May 2023

PACE Part D Choice Act of 2023 This bill allows Medicare-only beneficiaries who are enrolled in Programs of All-Inclusive Care for the Elderly (PACE) to choose prescription drug plans that are not operated by PACE. (PACE is a program under Medicare and Medicaid that provides in-home and community services for certain individuals as an alternative to nursing home care.) Specifically, the bill allows PACE enrollees who are Medicare (but not Medicaid) beneficiaries to choose a prescription drug plan that is not a Medicare Advantage plan or operated by PACE and for which annual out-of-pocket costs and federal subsidies are equal to or less than that under the applicable PACE prescription drug plan. The bill also allows for disenrollment from a chosen plan upon a change in medication or demonstration of an unexpected increase in out-of-pocket costs. PACE programs must conduct outreach, monitor data, and coordinate benefits with respect to such options.

Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2023

United States · United States Congress · 18 May 2023

Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2023 This bill establishes a reciprocal marketing approval process that allows for the sale of a drug, biological product, or medical device that has not been approved by the Food and Drug Administration (FDA) if the product is approved for sale in another country and there is an unmet need. Specifically, in order to receive reciprocal approval, the bill requires the product's sponsor to demonstrate, among other things, that (1) the product has been approved in one of the specified countries, (2) neither the FDA nor any of the specified countries have withdrawn approval for the product because of safety or effectiveness concerns, and (3) there is a public health or unmet medical need for the product. The FDA may decline approval if the FDA determines that the product is not safe or effective. The FDA may condition reciprocal approval on the conduct of postmarket studies. The FDA must issue a decision on whether to grant a request for reciprocal marketing approval within 30 days of receiving the request. Congress may pass a joint resolution to grant reciprocal marketing approval of a product that the FDA declines to approve through the reciprocal process.

Access to Safe Contraception Act of 2023

United States · United States Congress · 18 May 2023

Access to Safe Contraception Act of 2023 This bill prohibits states from banning any form of contraception that is approved by the Food and Drug Administration. The bill does not preempt state laws that protect the right of any entity to opt out of providing contraception due to the entity's religious or moral beliefs.

Pursuing Equity in Mental Health Act

United States · United States Congress · 18 May 2023

Pursuing Equity in Mental Health Act This bill sets out activities and modifies existing programs to address racial and ethnic mental health disparities. Specifically, the Department of Health and Human Services (HHS) must implement a strategy for promoting behavioral and mental health and reducing stigma associated with mental health conditions and substance use disorder among racial and ethnic minority groups. HHS must consult with appropriate advocacy groups and behavioral health organizations on this strategy. Additionally, HHS must seek to contract with the National Academies of Sciences, Engineering, and Medicine for a study on research gaps related to mental health disparities among racial and ethnic minority groups. Modifications to existing programs include (1) permitting HHS to prioritize health care facilities that serve a high proportion of racial and ethnic minority groups when awarding grants for integrating physical and behavioral health care, and (2) extending the authorization for the grants from FY2027 through FY2029. The bill also permits the use of funds available through the Minority Fellowship Program for developing best practices or core competencies to address mental health disparities in curricula for training social workers, psychologists, and other behavioral health professionals. (This program supports the education and training of minority students who are studying for advanced degrees in a mental or behavioral health profession.)

NIH Clinical Trial Diversity Act of 2023

United States · United States Congress · 18 May 2023

NIH Clinical Trial Diversity Act of 2023 This bill sets out requirements to increase the diversity of clinical trial participants and requires other activities to foster participation in clinical trials. As a condition of approval from the National Institutes of Health (NIH) for a clinical trial investigating a drug, device, or behavioral intervention, a sponsor's application must include certain information related to diversity in its trial, such as goals for recruiting and retaining trial participants, plans for achieving the recruitment and retention goals and implementing less-burdensome clinical trial follow-up requirements, and requirements for researchers and other individuals involved with the trial to complete education and training about diversity in clinical trials. A sponsor must also annually share demographic data of clinical trial participants with the NIH. The NIH must publish on its website information about the diversity of and other information concerning the clinical trials it funds. If a sponsor fails to meet its diversity goals or related requirements, the sponsor must develop and implement a strategic plan to increase the diversity of the clinical trial participants. Further, the NIH and the Food and Drug Administration must carry out a national campaign to increase awareness about the need for diverse clinical trials. The bill also requires studies on barriers to participation in clinical trials. The Government Accountability Office must study actions taken by federal agencies to address such barriers while the NIH must study regulations that govern reimbursements of out-of-pocket expenses of and incentives for clinical trial participants.

Supporting the designation of July 19, 2023, as "Glioblastoma Awareness Day".

United States · United States Congress · 18 May 2023

This resolution supports the designation of Glioblastoma Awareness Day. Glioblastoma is a malignant brain tumor.

Perinatal Workforce Act

United States · United States Congress · 18 May 2023

Perinatal Workforce Act This bill establishes programs and requires research to diversify the perinatal workforce and advance respectful maternal care delivery models. Specifically, the Department of Health and Human Services (HHS) must award grants to education and training programs to grow and diversify the professions that make up the perinatal workforce. HHS must also disseminate guidance on respectful maternal care delivery. This guidance must cover, among other topics, recruiting and retaining maternity care providers from diverse backgrounds and incorporating trained midwives and other perinatal health workers into maternity care teams. In addition, the National Institutes of Health must study best practices for culturally and linguistically congruent maternity care. This is care that is in agreement with the preferred cultural values, beliefs, languages, worldview, and practices of health care consumers and other stakeholders. The Government Accountability Office must also report on certain aspects of perinatal health care professions. The report must focus on barriers to entering those professions for low-income and minority women.

Ensuring Seniors’ Access to Quality Care Act

United States · United States Congress · 18 May 2023

Ensuring Seniors' Access to Quality Care Act This bill repeals certain restrictions under Medicare and Medicaid that prohibit the approval of nurse-aide training and competency evaluation programs in skilled nursing facilities that have been subject to specified regulatory actions (e.g., civil penalties) for substandard quality of care. The Centers for Medicare & Medicaid Services (CMS) must still disapprove such programs for up to two years; however, the CMS must rescind the disapproval upon completion of corrective action and may require additional oversight of the program for purposes of rescission. The bill also allows Medicaid and Medicare providers (e.g., skilled nursing facilities) to access, through the National Practitioner Data Bank, disciplinary information for affiliated physicians and other health care practitioners, as reported by state licensing authorities.

Data on Interactions and Accountability for Law Enforcement with Individuals with Disabilities Act

United States · United States Congress · 18 May 2023

Data on Interactions and Accountability for Law Enforcement with Individuals with Disabilities Act This bill expands activities to collect data about interactions between law enforcement officers and individuals with disabilities. In particular, the bill establishes a temporary advisory council within the Department of Health and Human Services (HHS) to develop a methodology for collecting and reporting data on interactions between law enforcement officers and individuals with disabilities. HHS must award a grant to an independent research organization or institution of higher education to test the validity and reliability of the council's methodology. The council must also provide the Department of Justice with best practices to collect disability status in cases where a death or injury occurred because of an interaction with law enforcement. The bill also requires certain federal initiatives that collect information about interactions with law enforcement (e.g., the National Use-of-Force Data Collection) to include disability status. Further, the Bureau of Justice must award a grant to an independent third-party organization (e.g., an institution of higher education) for identifying trends using certain survey data in violence committed by law enforcement officers against individuals with disabilities.

Perinatal Workforce Act

United States · United States Congress · 18 May 2023

Perinatal Workforce Act This bill establishes programs and requires research to diversify the perinatal workforce and advance respectful maternal care delivery models. Specifically, the Department of Health and Human Services (HHS) must award grants to education and training programs to grow and diversify the professions that make up the perinatal workforce. HHS must also disseminate guidance on respectful maternal care delivery. This guidance must cover, among other topics, recruiting and retaining maternity care providers from diverse backgrounds and incorporating trained midwives and other perinatal health workers into maternity care teams. In addition, the National Institutes of Health must study best practices for culturally and linguistically congruent maternity care. This is care that is in agreement with the preferred cultural values, beliefs, languages, worldview, and practices of health care consumers and other stakeholders. The Government Accountability Office must also report on certain aspects of perinatal health care professions. The report must focus on barriers to entering those professions for low-income and minority women.

Pursuing Equity in Mental Health Act

United States · United States Congress · 18 May 2023

Pursuing Equity in Mental Health Act This bill sets out activities and modifies existing programs to address racial and ethnic mental health disparities. Specifically, the Department of Health and Human Services (HHS) must implement a strategy for promoting behavioral and mental health and reducing stigma associated with mental health conditions and substance use disorder among racial and ethnic minority groups. HHS must consult with appropriate advocacy groups and behavioral health organizations on this strategy. Additionally, HHS must seek to contract with the National Academies of Sciences, Engineering, and Medicine for a study on research gaps related to mental health disparities among racial and ethnic minority groups. Modifications to existing programs include (1) permitting HHS to prioritize health care facilities that serve a high proportion of racial and ethnic minority groups when awarding grants for integrating physical and behavioral health care, and (2) extending the authorization for the grants from FY2027 through FY2029. The bill also permits the use of funds available through the Minority Fellowship Program for developing best practices or core competencies to address mental health disparities in curricula for training social workers, psychologists, and other behavioral health professionals. (This program supports the education and training of minority students who are studying for advanced degrees in a mental or behavioral health profession.)

A resolution designating May 2023 as "ALS Awareness Month".

United States · United States Congress · 18 May 2023

This resolution designates May 2023 as ALS Awareness Month. Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease, also known as Lou Gehrig's disease, that affects nerve cells in the brain and spinal cord.

A resolution promoting minority health awareness and supporting the goals and ideals of National Minority Health Month in April 2023, which include bringing attention to the health disparities faced by minority populations of the United States such as American Indians, Alaska Natives, Asian Americans, African Americans, Hispanics, and Native Hawaiians or other Pacific Islanders.

United States · United States Congress · 18 May 2023

This resolution expresses support for National Minority Health Month.

Tech to Save Moms Act

United States · United States Congress · 18 May 2023

Tech to Save Moms Act This bill supports the use of technology to improve, and address disparities in, maternal health outcomes. Specifically, the Center for Medicare and Medicaid Innovation may test telehealth models to screen and treat common pregnancy-related complications for Medicaid enrollees. In addition, the Department of Health and Human Services (HHS) must award grants to evaluate and expand the use of technology-enabled collaborative learning models by entities that provide services to pregnant and postpartum individuals in medically underserved areas or from certain populations, and reduce racial and ethnic disparities in maternal health outcomes by increasing access to digital tools. HHS must also contract with the National Academies of Sciences, Engineering, and Medicine to study the use of technology in maternal health care.

BENES 2.0 Act

United States · United States Congress · 18 May 2023

Beneficiary Enrollment Notification and Eligibility Simplification 2.0 Act or the BENES 2.0 Act This bill requires Social Security account statements for individuals attaining ages 60 to 65 to include information about Medicare eligibility, late enrollment penalties, benefit coordination, and related resources. Statements with the required information must be mailed to individuals at least three months before they turn 65; the required information must also be mailed to those who are age 65 or over and are entitled to Social Security benefits three months before their initial Medicare enrollment period begins.

Affordability is Access Act of 2023

United States · United States Congress · 18 May 2023

Real Education and Access for Healthy Youth Act of 2023

United States · United States Congress · 18 May 2023

Real Education and Access for Healthy Youth Act of 2023 This bill requires the Department of Health and Human Services (HHS) to establish grants to support sex education and sexual health services for young people (ages 10 through 29) and repeals requirements that apply to certain federally funded sex education programs. HHS must award grants, in coordination with the Department of Education, to (1) provide sex education to young people; and (2) train education professionals to effectively teach, and otherwise support, sex education. Sex education refers to high quality teaching and learning that follows, to the maximum extent practicable, specified educational standards; covers a variety of topics concerning sex and sexuality; explores values and beliefs about those topics; and helps young people gain skills to navigate relationships and manage sexual health. Additionally, HHS must award grants to youth-serving organizations and health care entities that are eligible to receive covered outpatient drugs at reduced prices through the 340B drug discount program for providing sexual health services to marginalized youth. Recipients of any of these grants must comply with certain nondiscrimination requirements. In addition, they may not use funds for sex education programs or sexual health services that provide incomplete or inaccurate medical information or fail to address specified issues. The bill also eliminates prohibitions regarding the content of specified federally funded sexual health education and information programs and repeals the Abstinence Only Until Marriage program.

Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2023

United States · United States Congress · 18 May 2023

Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2023 This bill establishes a reciprocal marketing approval process that allows for the sale of a drug, biological product, or medical device that has not been approved by the Food and Drug Administration (FDA) if the product is approved for sale in another country and there is an unmet need. Specifically, in order to receive reciprocal approval, the bill requires the product's sponsor to demonstrate, among other things, that (1) the product has been approved in one of the specified countries, (2) neither the FDA nor any of the specified countries have withdrawn approval for the product because of safety or effectiveness concerns, and (3) there is a public health or unmet medical need for the product. The FDA may decline approval if the FDA determines that the product is not safe or effective. The FDA may condition reciprocal approval on the conduct of postmarket studies. The FDA must issue a decision on whether to grant a request for reciprocal marketing approval within 30 days of receiving the request. Congress may pass a joint resolution to grant reciprocal marketing approval of a product that the FDA declines to approve through the reciprocal process.

PACE Part D Choice Act of 2023

United States · United States Congress · 18 May 2023

PACE Part D Choice Act of 2023 This bill allows Medicare-only beneficiaries who are enrolled in Programs of All-Inclusive Care for the Elderly (PACE) to choose prescription drug plans that are not operated by PACE. (PACE is a program under Medicare and Medicaid that provides in-home and community services for certain individuals as an alternative to nursing home care.) Specifically, the bill allows PACE enrollees who are Medicare (but not Medicaid) beneficiaries to choose a prescription drug plan that is not a Medicare Advantage plan or operated by PACE and for which annual out-of-pocket costs and federal subsidies are equal to or less than that under the applicable PACE prescription drug plan. The bill also allows for disenrollment from a chosen plan upon a change in medication or demonstration of an unexpected increase in out-of-pocket costs. PACE programs must conduct outreach, monitor data, and coordinate benefits with respect to such options.

Protecting Access to Ground Ambulance Medical Services Act of 2023

United States · United States Congress · 18 May 2023

Protecting Access to Ground Ambulance Medical Services Act of 2023 This bill extends a specialized rate increase for Medicare payment of ground ambulance services in rural areas for an additional three years (until January 1, 2028) and provides for a higher rate increase for services furnished between January 1, 2025, and January 1, 2028.

NIH Clinical Trial Diversity Act of 2023

United States · United States Congress · 18 May 2023

NIH Clinical Trial Diversity Act of 2023 This bill sets out requirements to increase the diversity of clinical trial participants. The bill also requires other activities to foster participation in clinical trials. As a condition of funding from the National Institutes of Health (NIH) for a clinical trial investigating a drug or device, a sponsor's application must include certain information related to diversity in its trial, such as goals for recruiting and retaining trial participants and plans for achieving the recruitment and retention goals and implementing less-burdensome clinical trial follow-up requirements. A sponsor must also annually share demographic data of clinical trial participants with the NIH. Further, the NIH and the Food and Drug Administration must carry out a national campaign to increase awareness about the need for diverse clinical trials.

HERMAN Act

United States · United States Congress · 18 May 2023

Healthcare Enrollment Reform Modernization and Navigation Act or the HERMAN Act This bill establishes and otherwise modifies requirements relating to coordinated coverage between employer health insurance and Medicare. Specifically, the bill prohibits employer-sponsored health plans for certain smaller employers from reducing benefits for employees who are eligible for Medicare but have not yet enrolled.

IMPROVING HEALTH CARE ACCESS IN RURAL COMMUNITIES: OBSTACLES AND OPPORTUNITIES

United States · United States Senate · 17 May 2023

HEARING ON WHY HEALTH CARE IS UNAFFORABLE: ANTICOMPETITIVE AND CONSOLIDATED MARKETS

United States · United States House of Representatives · 17 May 2023

EXAMINING HEALTH CARE DENIALS AND DELAYS IN MEDICARE ADVANTAGE

United States · United States Senate · 17 May 2023

To amend the Internal Revenue Code of 1986 to include expenses relating to membership in health care sharing ministries to qualify for the deduction for medical expenses, and for other purposes.

United States · United States Congress · 17 May 2023

This bill includes expenses for membership in health care sharing ministries as tax-deductible medical expenses. (Health care sharing ministries are faith-based organizations with members who share a common set of ethical or religious beliefs and who contribute regular payments to cover the medical expenses of other members.)

FAIR Act

United States · United States Congress · 17 May 2023

Facilitating Accountability In Reimbursements Act or the FAIR Act This bill requires health care providers to use separate, unique health identifiers when submitting a claim to a health insurance issuer for services provided at an off-campus outpatient department.

Telemental Health Care Access Act of 2023

United States · United States Congress · 17 May 2023

Telemental Health Care Access Act of 2023 This bill eliminates certain restrictions relating to Medicare coverage of mental health services that are provided through telehealth. Current law allows for coverage of such services regardless of the geographic location of the originating site (i.e., the location of the beneficiary), as long as the beneficiary previously received in-person services and continues to receive in-person services at specified intervals (effective January 1, 2025). The bill eliminates these in-person requirements.

Medicare for All Act

United States · United States Congress · 17 May 2023

Medicare for All Act This bill establishes a national health insurance program that is administered by the Department of Health and Human Services (HHS). Among other requirements, the program must (1) cover all U.S. residents; (2) provide for automatic enrollment of individuals upon birth or residency in the United States; and (3) cover items and services that are medically necessary or appropriate to maintain health or to diagnose, treat, or rehabilitate a health condition, including hospital services, prescription drugs, mental health and substance abuse treatment, dental and vision services, long-term care, gender affirming care, and reproductive care, including contraception and abortions. The bill prohibits cost-sharing (e.g., deductibles, coinsurance, and copayments) and other charges for covered services. Additionally, private health insurers and employers may only offer coverage that is supplemental to, and not duplicative of, benefits provided under the program. Health insurance exchanges and specified federal health programs terminate upon program implementation. However, the program does not affect coverage provided through the Department of Veterans Affairs or the Indian Health Service. The bill also establishes a series of implementing provisions relating to (1) health care provider participation; (2) HHS administration; and (3) payments and costs, including the requirement that HHS negotiate prices for prescription drugs. Individuals who are age 18 or younger, age 55 or older, or already enrolled in Medicare may enroll in the program starting one year after enactment of this bill; other individuals may buy into the program at this time. The program must be fully implemented two years after enactment.

Protecting Rural Telehealth Access Act

United States · United States Congress · 17 May 2023

Protecting Rural Telehealth Access Act This bill expands coverage of telehealth services under Medicare. Specifically, the bill permanently (1) removes geographic restrictions on originating sites (i.e., the location of the beneficiary), (2) allows the home of the beneficiary to serve as the originating site for all services, (3) allows federally qualified health centers and rural health clinics to serve as the distant site (i.e., the location of the health care practitioner), and (4) expands coverage to include audio-only services for evaluation and management and behavioral health services.

Give Kids a Chance Act of 2024

United States · United States Congress · 17 May 2023

Give Kids a Chance Act of 2023 This bill authorizes certain targeted clinical trials involving combinations of drugs to treat pediatric cancer. Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations so as to authorize investigations of new drugs that are used in combination with active ingredients that have already been approved and that (1) have been determined to be the standard of care for treating a pediatric cancer, or (2) have been approved to treat an adult cancer and are directed at molecular targets for pediatric cancer. The Food and Drug Administration must issue guidance and report on the bill's implementation. The Government Accountability Office must report on the effectiveness of the bill's changes with respect to the development of pediatric cancer drugs.

Expressing support for the designation of May as Ehlers-Danlos Syndrome Awareness Month to increase the knowledge of this little-known, potentially fatal, genetic disease.

United States · United States Congress · 17 May 2023

This resolution supports the designation of Ehlers-Danlos Syndrome Awareness Month. This syndrome is a group of inherited disorders that affect collagen in skin, joints, and other connective tissue.

Expanding Opportunities for Recovery Act of 2023

United States · United States Congress · 17 May 2023

Expanding Opportunities for Recovery Act of 2023 This bill requires the Center for Substance Abuse Treatment in the Substance Abuse and Mental Health Services Administration to award grants to states to expand access to clinically appropriate services for opioid abuse or addiction. States must use these grants to provide up to 60 consecutive days of services to individuals who otherwise would not have access to substance abuse services.